GOVEK; Steven P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for GOVEK; Steven P..The latest application filed is for "farnesoid x receptor agonists and uses thereof".
Company Profile
11.35.56
- GOVEK; Steven P. - San Diego CA
- Govek; Steven P. - 13216 Via Santillana San Diego CA
Patent Activity
| Patent | Date |
|---|---|
| Farnesoid X Receptor Agonists And Uses Thereof App 20220089575 - SMITH; Nicholas D. ; et al. | 2022-03-24 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20220081390 - SMITH; Nicholas D. ; et al. | 2022-03-17 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20220056019 - SMITH; Nicholas D. ; et al. | 2022-02-24 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20220054469 - SMITH; Nicholas D. ; et al. | 2022-02-24 |
| Farnesoid X receptor agonists and uses thereof Grant 11,236,071 - Smith , et al. February 1, 2 | 2022-02-01 |
| Farnesoid X receptor agonists and uses thereof Grant 11,214,538 - Smith , et al. January 4, 2 | 2022-01-04 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20210395253 - SMITH; Nicholas D. ; et al. | 2021-12-23 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20210300875 - SMITH; Nicholas D. ; et al. | 2021-09-30 |
| Farnesoid X receptor agonists and uses thereof Grant 11,084,817 - Smith , et al. August 10, 2 | 2021-08-10 |
| Farnesoid X receptor agonists and uses thereof Grant 10,961,198 - Smith , et al. March 30, 2 | 2021-03-30 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20210032195 - SMITH; Nicholas D. ; et al. | 2021-02-04 |
| Farnesoid X receptor agonists and uses thereof Grant 10,703,712 - Smith , et al. | 2020-07-07 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131142 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131134 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131129 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131132 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X receptor agonists and uses thereof Grant 10,626,081 - Smith , et al. | 2020-04-21 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200102308 - SMITH; Nicholas D. ; et al. | 2020-04-02 |
| Farnesoid X receptor agonists and uses thereof Grant 10,377,717 - Smith , et al. A | 2019-08-13 |
| Estrogen receptor modulators and uses thereof Grant 10,227,334 - Kahraman , et al. | 2019-03-12 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20190062277 - SMITH; Nicholas D. ; et al. | 2019-02-28 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20180282263 - SMITH; Nicholas D. ; et al. | 2018-10-04 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20180251429 - SMITH; Nicholas D. ; et al. | 2018-09-06 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20180244606 - SMITH; Nicholas D. ; et al. | 2018-08-30 |
| Heterocyclic estrogen receptor modulators and uses thereof Grant 10,053,451 - Labadie , et al. August 21, 2 | 2018-08-21 |
| Estrogen receptor modulators and uses thereof Grant 9,873,684 - Kahraman , et al. January 23, 2 | 2018-01-23 |
| Estrogen receptor modulators and uses thereof Grant 9,868,704 - Smith , et al. January 16, 2 | 2018-01-16 |
| Estrogen receptor modulators and uses thereof Grant 9,845,291 - Liang , et al. December 19, 2 | 2017-12-19 |
| Estrogen Receptor Modulators And Uses Thereof App 20170275273 - Kahraman; Mehmet ; et al. | 2017-09-28 |
| Estrogen Receptor Modulators And Uses Thereof App 20170197915 - Liang; Jun ; et al. | 2017-07-13 |
| Azetidine estrogen receptor modulators and uses thereof Grant 9,655,880 - Govek , et al. May 23, 2 | 2017-05-23 |
| Polycyclic estrogen receptor modulators and uses thereof Grant 9,586,952 - Smith , et al. March 7, 2 | 2017-03-07 |
| Azetidine Estrogen Receptor Modulators And Uses Thereof App 20160367526 - Govek; Steven P. ; et al. | 2016-12-22 |
| Polycyclic Estrogen Receptor Modulators And Uses Thereof App 20160355508 - Smith; Nicholas D. ; et al. | 2016-12-08 |
| Heterocyclic Estrogen Receptor Modulators And Uses Thereof App 20160347742 - Labadie; Sharada ; et al. | 2016-12-01 |
| Estrogen receptor modulators and uses thereof Grant 9,499,538 - Smith , et al. November 22, 2 | 2016-11-22 |
| Azetidine estrogen receptor modulators and uses thereof Grant 9,475,798 - Govek , et al. October 25, 2 | 2016-10-25 |
| Estrogen Receptor Modulators And Uses Thereof App 20160304450 - Liang; Jun ; et al. | 2016-10-20 |
| Estrogen Receptor Modulators And Uses Thereof App 20160297767 - Smith; Nicholas D. ; et al. | 2016-10-13 |
| Estrogen receptor modulators and uses thereof Grant 9,399,646 - Smith , et al. July 26, 2 | 2016-07-26 |
| Estrogen Receptor Modulators And Uses Thereof App 20160175284 - Labadie; Sharada ; et al. | 2016-06-23 |
| Estrogen Receptor Modulators And Uses Thereof App 20160090378 - Kahraman; Mehmet ; et al. | 2016-03-31 |
| Azetidine Estrogen Receptor Modulators And Uses Thereof App 20160090377 - Govek; Steven P. ; et al. | 2016-03-31 |
| Fluorinated estrogen receptor modulators and uses thereof Grant 9,193,714 - Smith , et al. November 24, 2 | 2015-11-24 |
| Estrogen receptor modulators and uses thereof Grant 9,187,460 - Smith , et al. November 17, 2 | 2015-11-17 |
| Bicyclic heteroaryl inhibitors of PDE4 Grant 9,078,887 - Govek , et al. July 14, 2 | 2015-07-14 |
| Estrogen receptor modulators and uses thereof Grant 9,078,871 - Kahraman , et al. July 14, 2 | 2015-07-14 |
| Estrogen Receptor Modulators And Uses Thereof App 20150105403 - Smith; Nicholas D. ; et al. | 2015-04-16 |
| Fluorinated Estrogen Receptor Modulators And Uses Thereof App 20150005286 - Smith; Nicholas D. ; et al. | 2015-01-01 |
| Estrogen Receptor Modulators And Uses Thereof App 20140364427 - Smith; Nicholas D. ; et al. | 2014-12-11 |
| Indane estrogen receptor modulators and uses thereof Grant 8,853,423 - Govek , et al. October 7, 2 | 2014-10-07 |
| Estrogen receptor modulators and uses thereof Grant 8,703,810 - Kahraman , et al. April 22, 2 | 2014-04-22 |
| Estrogen Receptor Modulators And Uses Thereof App 20140107095 - Kahraman; Mehmet ; et al. | 2014-04-17 |
| Estrogen Receptor Modulators And Uses Thereof App 20130231333 - Smith; Nicholas D. ; et al. | 2013-09-05 |
| Estrogen receptor modulators and uses thereof Grant 8,455,534 - Smith , et al. June 4, 2 | 2013-06-04 |
| Indane Estrogen Receptor Modulators And Uses Thereof App 20130137746 - Govek; Steven P. ; et al. | 2013-05-30 |
| Estrogen Receptor Modulators And Uses Thereof App 20130116232 - Kahraman; Mehmet ; et al. | 2013-05-09 |
| Bicyclic Heteroaryl Inhibitors Of Pde4 App 20130116279 - Govek; Steven P. ; et al. | 2013-05-09 |
| Bicyclic Heteroaryl Inhibitors Of Pde4 App 20130045975 - Govek; Steven P. ; et al. | 2013-02-21 |
| Estrogen Receptor Modulators And Uses Thereof App 20130012561 - SMITH; Nicholas D. ; et al. | 2013-01-10 |
| Estrogen receptor modulators and uses thereof Grant 8,299,112 - Smith , et al. October 30, 2 | 2012-10-30 |
| Estrogen Receptor Modulators And Uses Thereof App 20120071535 - SMITH; Nicholas D. ; et al. | 2012-03-22 |
| Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 Grant 8,138,205 - Govek , et al. March 20, 2 | 2012-03-20 |
| Bicyclic heteroaryl inhibitors of PDE4 Grant 8,080,563 - Govek , et al. December 20, 2 | 2011-12-20 |
| Benzazole potentiators of metabotropic glutamate receptors Grant 7,960,417 - Govek , et al. June 14, 2 | 2011-06-14 |
| Sulfonyl-substituted bicyclic compounds as modulators of PPAR Grant 7,834,004 - Noble , et al. November 16, 2 | 2010-11-16 |
| Aryl-substituted Heterocyclic Pde4 Inhibitors As Anti-inflammatory Agents App 20100105729 - Govek; Steven P. ; et al. | 2010-04-29 |
| Bicyclic Heteroaryl Inhibitors Of Pde4 App 20100081646 - Govek; Steven P. ; et al. | 2010-04-01 |
| Bicyclic Heteroaryl Inhibitors Of Pde4 App 20100022586 - Govek; Steven P. ; et al. | 2010-01-28 |
| Bicyclic Heteroaryl Inhibitors Of Pde4 App 20090291950 - Govek; Steven P. ; et al. | 2009-11-26 |
| Heterocyclic Inhibitors Of Pde4 App 20090275586 - Govek; Steven P. ; et al. | 2009-11-05 |
| Sulfonyl-substituted Bicyclic Compounds As Modulators Of Ppar App 20090264417 - Noble; Stewart A. ; et al. | 2009-10-22 |
| Sulfonyl-substituted Bicyclic Compounds As Modulators Of Ppar App 20090227599 - Noble; Stewart A. ; et al. | 2009-09-10 |
| Sulfonyl-substituted bicyclic compounds as modulators of PPAR Grant 7,494,999 - Noble , et al. February 24, 2 | 2009-02-24 |
| Novel Compounds as Modulators of Ppar App 20080287477 - Malecha; James W. ; et al. | 2008-11-20 |
| Benzazole Potentiators of Metabotropic Glutatmate Receptors App 20080176904 - Govek; Steven P. ; et al. | 2008-07-24 |
| Bicyclic Heteroaryl Inhibitors Of Pde4 App 20080027099 - Govek; Steven ; et al. | 2008-01-31 |
| Bicyclic Heteroaryl Inhibitors Of Pde4 App 20080027112 - Govek; Steven ; et al. | 2008-01-31 |
| Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 App 20070027321 - Kamenecka; Theodore M. ; et al. | 2007-02-01 |
| Sulfonyl-substituted bicyclic compounds as modulators of PPAR App 20060205736 - Noble; Stewart A. ; et al. | 2006-09-14 |
| Sulfonyl-substituted bicyclic compounds as modulators of PPAR App 20060167012 - Noble; Stewart A. ; et al. | 2006-07-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 